Synaptogenix, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
SNPX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1185 Avenue Of The Americas, 3 Rd Floor, New York, NY

There are no Buy or Sell transactions made by insiders since 10/25/2024

Synaptogenix, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joshua Silverman Executive Chairman, Director $627K Aug 6, 2025
Bruce Bernstein Director $223K Aug 6, 2025
William S. Singer Director $141K Aug 6, 2025
Robert Weinstein Chief Financial Officer $120K Aug 6, 2025
Jonathan Schechter Director $110K Aug 6, 2025
George Perry Director $46.9K Jul 13, 2021
Daniel L. Alkon President and CSO, Director $41.7K Dec 16, 2022
Robert Ephron Director $32.5K Oct 17, 2025
Alan J. Tuchman Chief Medical Officer, Director $30.7K Jun 30, 2025

Recent Insider Transactions by Companies or Individuals for Synaptogenix, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.